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Abstract 
 
Since the advent of next-generation sequencing in the early 2000s, the volume of bioinformatics software 
tools and databases has exploded and continues to grow rapidly. Documenting this evolution on a global and 
time-dependent scale is a challenging task, limited by the scarcity of comprehensive tool repositories. We 
collected data from over ~23,000 references classified in the OMICtools database, spanning the last 26 years 
of bioinformatics to present a data-supported snapshot of bioinformatics software tool evolution and the 
current status, to shed light on future directions and opportunities in this field. The present review explores 
new aspects of computational biology, including country partnerships, trends in technologies and area of 
development, research and development (R&D) investments and coding languages. This is the most 
comprehensive systematic overview of the field to date and provides the community with insights and 
knowledge on the direction of the development and evolution of bioinformatics software tools, highlighting 
the increasing complexity of analysis. 
 
 
Introduction 
 
Bioinformatics tools and databases constitute an 
integral component of the current research 
process in life and biomedical sciences. Since the 
introduction of information technology in 
biological research, a plethora of computational 
tools and databases have followed, contributing 
to major breakthroughs in the field. One such 
ground-breaking example is the development of 
Edman protein sequencing1 which generated a 
new form of data at the time, a protein sequence, 
and fostered the development of the Needleman-
Wunsch protein sequence alignment algorithm2. 
Today,  several more steps in the development of 
bioinformatics have been taken, with e.g. high-
throughput sequencing (HTS) experiments 
requiring highly sophisticated and specific 
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pipelines of analysis tools3,4. In the past decade, 
the notion of “biological data” has shifted in 
magnitude, from sets of hundreds to sets of 
millions and even billions of entities5,6. This 
exponential increase in the volume of biological 
data has stimulated the development of an ever-
increasing number of bioinformatics tools. 
Moreover, biological data have shifted in 
complexity, evolving from a gene-centric 
perspective to the systems level, and most tasks 
now involve computer-assisted reduction of large 
collected raw datasets for conversion into usable 
knowledge. 
A major challenge that today’s researchers face is 
to find the most appropriate and up-to-date tools 
and resources for their analyses. Online 
repositories and databases that centralize, 
reference, classify, and provide access to, 
available tools represent indispensable aids to the 
scientific community7. Moreover, these 
repositories represent a focused opportunity to 
mine for and exploit a wealth of existing 
information. 
Given the dramatic rate at which the field is 
evolving, still without any signs of decrease, 
unravelling of the evolutionary patterns of 
bioinformatics tools and databases is a complex 
challenge as we generate an ever-increasing 
amount of data and knowledge on how to store, 
process, analyze and visualize biological data. 
While a variety of specialized reviews focusing on 
software tools for specific areas (e.g. protein 
structure prediction, secretome analysis, binding 
site identification, etc.) have been published, to 
our knowledge, the global perspective and state-
of-the-art of the field of “omics” bioinformatics 
tools is lacking. In this historical perspective, using 
a comprehensive bioinformatics tool repository, 
we discuss the early days of bioinformatics 
through to today and provide an illustrated 
snapshot of the evolution of bioinformatics in 
recent decades. 
 
The interlaced roots of bioinformatics 
The term “bioinformatics” is now widely 
recognized as an entire field that encompasses 
biology, medicine, computer science, 
mathematics, statistics, and information 
technology. Mainstream applications and 
concepts in bioinformatics include high-
throughput sequencing, “big data” and the 
internet. The origins of bioinformatics can be set 
in the late 1950s8,9. Since the publication of the 
DNA structure by Watson and Crick10, every major 
breakthrough in the study of genes and proteins 
has involved informatics technology. As the power 
and computational capabilities of machines have 
expanded, so too has our comprehension of the 
complexity of biology11.  
One of the earliest applications in biology for 
computers was the calculation of crystallographic 
structures of proteins, after John Kendrew solved 
the three-dimensional structure of myoglobin12. 
The same year, a computer was used for the first 
time to calculate and estimate genetic linkage13. 
The field of biochemistry rapidly followed on with 
the use of computers, driven by the accumulation 
of protein sequences after Frederick Sanger 
determined the sequence of bovine insulin in the 
early 1950s14. Margaret Oakley Dayhoff was the 
first to compile protein sequences in a database, 
published in a book format in the 1960s as 
the Atlas of Protein Sequence and Structure15, 
and to develop a computer-assisted sequence 
alignment and comparison program16,17. In the 
meantime, the nascent field of molecular 
evolution was revolutionized by the calculation 
power of computers to generate phylogenic 
trees18,19. 
By 1970, biologists had successfully developed 
and implemented computer programs for the 
study of protein structure, function, and 
evolution. After 1965, when the first gene 
sequences were available, it was straightforward 
for researchers to apply their programs to the 
biology of nucleic acids20,21. The same year, a new 
comparison method was successfully applied to 
both protein and nucleic acid sequences22. 
Likewise, novel computer programs were 
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developed for RNA structure prediction23, pairing 
schemes of RNA molecules24, DNA 
conformation25, and DNA sequence data handling 
(storage, edition, translation, comparison, etc.)26. 
In 1977, two new DNA sequencing methods were 
published27,28, which greatly extended the amount 
of nucleic acid sequences to be analyzed. 
In parallel with the growing application of 
computers in biology, the field of informatics itself 
was profoundly transformed with the creation of 
the ARPANET in 1969, predecessor of the internet 
and the World Wide Web that came much later in 
199229. Progressively, computers became more 
accessible for the average researcher. In 1981, 
IBM launched its first Personal Computer, and just 
three years later it was used to write a sequence 
analysis program, rendering large and expensive 
computers obsolete30. 
By the 1980s, bioinformatics was already at the 
crossroads of biology, biomedicine, computer 
science, medicine, statistics, mathematics and 
physics. It became mainstream in the late 1980s 
for the management and analysis of sequence 
data, protein structure determination, function 
prediction and phylogeny9. The progressive 
accumulation of data stimulated the creation of 
the first computer-based databases for gene and 
protein sequences. In the mid-80s, the GenBank 
and EMBL sequence libraries were launched, 
which, in the absence of a global interconnected 
network, at the time were stored and shared on 
floppy disks or local networks31,32. Sequence 
alignment programs soon became overwhelmed 
with thousands of sequences to be searched, 
aligned, and compared. To address this, the FASTA 
and BLAST database search algorithms were 
developed and are still widely used33,34. 
 
Bioinformatics in the genomics era 
 
Bioinformatics entered a new era in the 1990s 
with the advent of genomics, a term used to 
describe the scientific discipline of mapping, 
sequencing, and analyzing whole genomes to 
understand organismal biology in a systems-level 
approach. The first generations of automated 
sequencing machines were introduced in 1986 by 
Applied Bioscience and used the Sanger 
sequencing method. This revolutionary 
technology paved the way to the long-awaited 
whole-genome sequencing of prokaryotic and 
eukaryotic model organism35,36, and the 
completion of the Human Genome Project in the 
early 2000s37,38. This in turn opened the door to a 
new field of biology, systems biology, dedicated to 
the study of interactions and networks within 
biological systems as a whole39. 
In the past two decades, the success of the Human 
Genome Project and the high demand for low-cost 
sequencing has fostered the development of 
“next-generation” sequencing (now referred to as 
“high-throughput” sequencing), which not only 
applies to genome sequencing, but also to 
transcriptome profiling (RNA-sequencing), DNA-
protein interactions (ChIP-sequencing), 
epigenome characterization, evaluation of DNA 
methylation (BS-seq) and much more40. While 
bioinformatics initially primarily revolved around 
sequence analysis, genomics and proteomics, 
today this domain has expanded to encompass the 
handling of many types of biological data, 
including text-mining data, imaging, mass 
spectrometry, flow-cytometry data, etc. 
Recent bioinformatics is marked by the 
development of an unparalleled number of 
software and computational tools, devoted to 
dealing with massive and ever-increasing amounts 
of data, with the number now doubling in under 
two years41. Handling, processing and storing 
information have become new challenges for 
biologists, embodied in a single concept - big data, 
a term to describe the challenge of dealing with 
several terabytes of data. An additional challenge 
that the newly developed tools are facing is how 
to extract, interpret and conceptualize the 
inherently complex cellular systems and processes 
from voluminous, yet relatively simple, collected 
datasets. To help biologists navigate in this 
challenging environment, a number of initiatives  
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have emerged with the goal to classify, index, and 
share a maximum of available tools7,42–44. 
 
Evolution of bioinformatics tools  
 
While the origins of bioinformatics can be easily 
retraced and reviewed, it is much more difficult to 
consider its evolution over the past decade, 
mainly because the key messages are lost in the 
wealth of repositories, databases, and 
publications available online. Who are the main 
providers of bioinformatics tools? What are the 
promising and trending fields in bioinformatics, 
and which areas are losing interest? To answer 
these questions, we used the freely accessible 
OMICtools database7 to extract a compilation of 
data on bioinformatics tools with the goal to 
provide a perspective on the evolution of modern 
bioinformatics tool development.  
Among all currently available bioinformatics tools 
repositories, OMICtools indexes the largest 
number of entries, and provides a comprehensive, 
updated ontology-based classification system that 
tracks various pertinent parameters and metadata 
for each tool. This includes its technology and/or 
analysis step, the date and journal of publication, 
country and institute of development, coding 
language, availability, past and current versions 
and usage scenario7,45. The repository includes 
bioinformatics tools identified and extracted from 
scientific publications and software repositories 
using automated mining algorithms which were 
subsequently manually curated and categorized. 
We analyzed data from over ~23,000 tools 
developed between 1990 and 2017. This 
comprehensive dataset enables us to analyze the 
bioinformatics tools landscape in various contexts, 
including the growth of available tools, their 
popularity or their lifespan throughout the years 
(Supplementary Figure 1). For the sake of 
simplicity, in this review, we apply the term “tool” 
for either a software tool or a database resource. 
Since the 2000s and the completion of the Human 
Genome Project, the number of tools being 
developed has grown exponentially, today 
doubling in under four years (Figure 1a); to put this 
in perspective, five times more tools were 
published in the last year than the total number of 
tools published between 1990 and 2000. This 
trend clearly brings to light an increasing challenge 
for researchers: finding the right tool for optimal 
data analysis in a constantly changing field.  
 
Tools applications and technologies 
 
In the OMICtools database, bioinformatics tools 
are classified according to their scope, in one or 
several of the following categories: genomics, 
transcriptomics, proteomics, metabolomics, 
epigenomics or phenomics. Figure 1b presents the 
number of tools produced each year since 1990 
according to omics application, demonstrating 
that all of the primary omics fields have seen a 
constant increase in the annual production of 
tools since the early 90s. 
To follow the dynamics of omics technologies, the 
annual production of bioinformatics tools 
dedicated to well-known applications in HTS, 
microarrays, PCR, mass-spectrometry, nuclear-
magnetic resonance (NMR), flow-cytometry (FC) 
and bioimaging  are presented in Figure 1c. New 
technologies in HTS, such as RNA-sequencing and 
single-cell RNA-sequencing, generated a rapid and 
exponential increase in the number of dedicated 
tools, while the rate of tool production in 
microarrays or Sanger sequencing, that predate 
new high-throughput technologies, are 
plateauing. Since a given tool can be used for more 
than one technology or analysis step, we extracted 
the number of duplications for each tool, that is 
the number of applications, analysis step, or 
function associated with a tool. The vast majority 
of tools in our database (82%) are assigned to one 
application, while 18% of tools are assigned to two 
or more applications (Supplementary Figure 2). 
 
Tool development worldwide 
 
Tool development and publication is dominated 
by the USA, with 9841 out of 30,141 (32,6%) 
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affiliations on published tools being US institutions 
(Figure 2a and b, full list of countries provided in 
Table 1). Most leading tool-developing institutions 
are hosted by European and American continents, 
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Figure 1: Evolution of bioinformatics tools from 1990 to 2017. 
(a) Cumulative production of tools among 23,201 tools classified in the OMICtools repository. (b) Evolution of the 
number of tools produced annually according to main omics field. (c) Number of tools published annually from 1990 to 
2017 by main omics technology. Sub-technologies that belong to a specific omics fields are color-coded. qPCR tools can 
be either classified as genomics or transcriptomics technology and are therefore represented in gray. HTS: High-
throughput sequencing; MS: Mass spectrometry; NMR: Nuclear-magnetic resonance; FC: Flow-cytometry; WGS: Whole-
genome sequencing; WES: Whole-exome sequencing; SS: Sanger sequencing; Ω: Omics. Data were transformed in Log2 
for better clarity. 
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with 18 out of the top 20 tool-developing 
institutes and universities located in the USA, 
United Kingdom, Canada, or rest of Europe 
(Supplementary Figure 3). 
Interestingly, supplementing the specialized 
bioinformatics-centered institutions, institutes 
and universities leading in life sciences also have 
ample in-house capacity to produce their own 
tools and resources. Indeed, bioinformaticians are 
highly sought after profiles in every biology lab46. 
Strikingly, no African countries appear in the top 
30 tool-developing countries (Table 1), although 
this might change with the new H3Africa initiative 
begun in 2010 and other national initiatives47,48. 
Despite awareness and progressive efforts to 
increase accessibility of knowledge of 
bioinformatics and computing skills, tool 
development remains largely the domain of 
countries with advanced scientific and financial 
resources49, even though open access and open 
data have created opportunities for those with 
capable internet access and relatively modest 
compute facilities. Figure 2c shows a high 
correlation (r=0.81; p<0.0001) between a 
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Figure 2: Tool development worldwide. 
(a) Number of tools published per countries (top 20). (b) Color-coded world map representation of the number of 
tools produced per country. (c) Correlation between research and development expenditure (UNESCO data) and 
total number of tools produced by the top 20 countries with highest Gross Domestic Product (GDP). 
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country’s research and development (R&D) 
expenditure in GDP and the number of tools 
published by one of its institutions.  
Scientific research relies heavily on collaborations 
between international institutions. Similarly, 
publications of bioinformatics tools often result 
from collaborations. In our database, a total of 
5063 published tools are affiliated with more than 
one unique country (Figure 3a). This translates 
into approximately 22% (5063 out of 22,891 tools 
for which information was retrieved) of tools 
developed through an international collaboration. 
Among those, figure 3b represents the network 
formed by the top 40 collaborative pairs of 
countries. The USA interacts widely, participating 
in the highest number of collaborations, 
distributed between the UK (17.3%), China 
(16.8%), Germany (12.3%), and the rest of Europe 
and Asia (Figure 3c). In contrast, the USA 
represents the vast majority (74%) of China’s 
collaborations for tool development (Figure 3d). 
This analysis also highlights interesting 
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Figure 3: Collaborations for tool development. 
(a) Number of unique affiliated countries per tool publication, among a total of 22,891 tools. (b-d) Network formed by 
the top 40 paired collaborations for tool publications. The total number of collaborations are shown for all countries (b) 
and between paired  countries (c and d). If a tool publication has more than 2 affiliated countries, each pair is counted. 
An interactive version of these collaborations is available at https://omictools.com/bioinformatics-trends#chord-graph. 
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parameters that potentially play a role in 
promoting collaboration between countries, such 
as geographical proximity (Australia and China) 
and common spoken languages (France and 
Switzerland, Austria and Germany). 
 
Economics of tool development 
 
Funding is a critical aspect of tool development. 
We ranked the sources of funding agencies 
associated with a total of 12,761 published tools 
to assess the top 20 tool-funding agencies 
worldwide (Figure 4). Nearly half of all published 
tools were funded by the National Institutes of 
Health (NIH) or the National Science Foundation 
(NSF), both US-based agencies. Over the past few 
years (and arguably since its foundation), the field 
of bioinformatics has developed in the direction of 
both open-source data and software. Freely 
available tools and frameworks have already 
served as a foundation for building important 
applications and resources50. In the OMICtools 
database, 270 out of 7,838 (3.4%) tools with a 
known license are registered with a commercial 
license while the remaining 7,568 tools are open-
source (data not shown), confirming the 
commitment of bioinformatics tools developers to 
support open science. 
 
Bioinformatics tools in the literature 
 
Nearly eight out of ten tools in the database have 
been published in a peer-reviewed journal (Figure 
5a), with 41.7% of all tools cited at least once, 
while 36.0% have never been cited in the 
literature. We analyzed the extent of tool citation 
in relation to the timing of development of a new 
technology, taking into account their publication 
age. (Figure 5b). A clear trend emerged as seen 
with the example of RNA-sequencing technology, 
with the first papers published in 2008; tools 
dedicated to analysis of RNA-sequencing data that 
were published in 2009 are on average 
significantly more cited that tools published in 
subsequent years (P <0.05). This trend was 
observed with other technologies including WGS, 
CHIP-seq and CLIP-seq, suggesting that tools that 
are the first to resolve a problem are more likely 
to be established as gold standards or default 
methods, and by consequence accumulate more 
citations over time.  
 
Tool specifications 
 
The user can run bioinformatics software tools 
either on the web, locally on a desktop or server, 
or both. While tools that can be used on the web 
could be expected to be more common, reflecting 
the need for user-friendliness for less-skilled 
users, we in fact found that more than 69% of the 
20,918 tools registered as software are developed 
as desktop applications only (Figure 6a). Similarly, 
we speculated that the majority of tools could be 
run on the mainstream operating systems (OS) 
Windows and Mac OS; we in fact found that more 
than half of the 15,736 tools with a known OS can 
be run on UNIX/Linux exclusively (Figure 6b). 
Moreover, 42.6% of tools are usable on more than 
one OS (34.2% on all three). Figure 6c represents 
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Figure 4: Top funding agencies. 
Number of published tools by funding institutions (top 
20). 
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the number of tools produced each year by the 
top-6 most used programming languages, plus 
Fortran and Javascript. Interestingly, while Java 
was the most used programming language each 
year from 2000 to 2010, it has now been 
surpassed by R, Python, and C++.  
Overall, these results likely reflect the fact that 
software tools are usually developed to address a 
need, pipeline, or problem that is specific to their 
developer, and are not necessarily designed to be 
easy-to-use for the average biologist. These data 
also indicate that tool development remains a 
field that requires specific sets of skills and 
highlights the importance of interactions between 
the biologists who use them and the 
bioinformaticians creating them. 
 
From individual tools to pipelines 
 
For an arguably extended period, biological data 
consisted of a handful of sequences to be analyzed 
and compared, which could be done in a few 
computational steps and by using a single 
program. However, due to their complexity and 
quantity, to obtain meaningful data, today’s 
biological datasets require multiple analysis steps 
that often need a series of different programs that 
must be run in a specific order. To verify this, we 
followed the evolution of co-citations (the number 
of tools cited per publication) and observed an 
increase in the number of tools jointly cited in 
scientific publications over time (Figure 7). While 
publications in the early 2000s were citing one to 
five tools at most, the number of tools cited per 
publication has continuously increased since 
2005, with 20% of publications in 2015 citing more 
than six tools. This indicates a shift in biological 
data complexity, now requiring the use of 
pipelines of tools for effective and productive 
analysis. 
 
Conclusion 
 
The present review proposes an illustrated and 
data-supported historical perspective of the 
evolution of bioinformatics since the 1990s. By 
collecting, sorting, and analyzing freely available 
data from more than ~23,000 bioinformatics 
tools, we provide a collection of original insights 
into the subtleties of this field. After years of 
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Figure 5: Bioinformatic tools in the literature. 
(a) Proportion of tools in the OMICtools database that are not associated with a PMID (gray), that have a PMID but 
have never been cited (yellow), or that have been cited at least once (blue). (b) Mean citation score of all tools for RNA-
sequencing analysis by publication year. For each tool with an associated PMID, the citation score is the number of time 
this tool has been cited in the literature divided by its publication age (the number of year since its publication; 2017 - 
year of publication). The bar plot represents the mean citation score for all tools published in a given year + standard 
error of mean (SEM). Statistical significance is indicated by *p < 0.05, ****p < 0.0001. Kruskal-Wallis multiple 
comparison test was used to compare every group to the “2009” group. ns: not significant. 
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parallel development, biology and informatics 
joined forces in the early 60s to rapidly become a 
major field in the biological sciences, dedicated to 
the handling and analysis of omics data. The last 
decade has seen a rapid expansion in the number 
of bioinformatics tools. Initially developed by 
biologists in need to respond to a specific question 
and accelerate their data analyses, they are now 
complex pieces of software that require advanced 
programming and coding knowledge. They 
necessitate a growing amount of time investment 
and financial resources, they are increasingly 
developed by extensive collaborative networks, 
and are published in high-quality peer-reviewed 
journals. The acknowledged scientific value of 
bioinformatics tools will only increase and expand 
to include other fields in the future. Here we 
highlight some insights from developments since 
the inception of the field, which shed light on the 
short-term direction and optimization of data 
analysis using bioinformatics tools.  
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Paradoxically, while bioinformatics tools were 
designed to deal with “big data”, their 
proliferation now raises concerns about a possible 
“big tool” pool, representing several resources so 
great that researchers primary challenge will be 
locating and choosing the right tools in order to 
explore their data. While databases and 
repositories propose the indexation of a 
considerable number of tools, they have trouble 
keeping pace with their constantly growing 
publication rate. As our data analyses suggest, 
analysis of complex biological datasets 
increasingly requires software to be run in 
pipelines of tools. Future challenges for biologists 
will thus include rapid identification of the most 
appropriate and functional combinations of tools, 
and the execution of these pipelines in a fully-
automated manner, with a minimum of resources 
and time, requiring the increasing involvement of 
machine learning and artificial intelligence 
methods, not only in data analysis, but also in tool 
selection.  
 
Methods  
 
On December 8th 2017, a total of 23,201 tool 
entries were extracted from the OMICtools 
database (https://omictools.com). The following 
data were retrieved (if available): date of creation, 
ontology (OMICtools classification), journal of 
publication, number of citations, countries and 
institutions associated with authors, source of 
funding, programming language and 
specifications, and the URL of the tool. To draw a 
correlation between countries’ R&D expenditure 
and number of tools produced, data from UNESCO 
(gross domestic expenditure on R&D, available at 
http://data.uis.unesco.org/Index.aspx and 
accessed in January 2018) for the top-20 countries 
with the highest GDP, were used.  
To evaluate the impact of publication year on 
mean citation number, we calculated a mean 
“citation score” for all RNA-sequencing analysis 
tools by publication year. To account for the fact 
that older articles tend to accumulate more 
citations, we divided the citation count for each 
tool with an associated PMID by its publication 
age, calculated as 2017 minus the year of 
publication, and expressed mean citation scores 
by years. Tool duplications within the RNA-
sequencing category were removed, and tools 
with zero citations were kept in the analysis. A 
Kruskal-Wallis multiple comparison test was used 
to compare every group to the “2009” group.  
Some figures of this article are dynamic and 
available at 
https://omictools.com/bioinformatics-trends. 
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